Cargando…
DSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort
Variants in desmoplakin gene (DSP MIM *125647) have been usually associated with Arrhythmogenic Cardiomyopathy (ACM), or Dilated Cardiomyopathy (DCM) inherited in an autosomal dominant manner. A cohort of 18 probands, characterized as heterozygotes for DSP variants by a target Next Generation Sequen...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916412/ https://www.ncbi.nlm.nih.gov/pubmed/36768812 http://dx.doi.org/10.3390/ijms24032490 |
_version_ | 1784886119727366144 |
---|---|
author | Di Lorenzo, Francesca Marchionni, Enrica Ferradini, Valentina Latini, Andrea Pezzoli, Laura Martino, Annamaria Romeo, Fabiana Iorio, Annamaria Bianchi, Stefano Iascone, Maria Calò, Leonardo Novelli, Giuseppe Mango, Ruggiero Sangiuolo, Federica |
author_facet | Di Lorenzo, Francesca Marchionni, Enrica Ferradini, Valentina Latini, Andrea Pezzoli, Laura Martino, Annamaria Romeo, Fabiana Iorio, Annamaria Bianchi, Stefano Iascone, Maria Calò, Leonardo Novelli, Giuseppe Mango, Ruggiero Sangiuolo, Federica |
author_sort | Di Lorenzo, Francesca |
collection | PubMed |
description | Variants in desmoplakin gene (DSP MIM *125647) have been usually associated with Arrhythmogenic Cardiomyopathy (ACM), or Dilated Cardiomyopathy (DCM) inherited in an autosomal dominant manner. A cohort of 18 probands, characterized as heterozygotes for DSP variants by a target Next Generation Sequencing (NGS) cardiomyopathy panel, was analyzed. Cardiological, genetic data, and imaging features were retrospectively collected. A total of 16 DSP heterozygous pathogenic or likely pathogenic variants were identified, 75% (n = 12) truncating variants, n = 2 missense variants, n = 1 splicing variant, and n = 1 duplication variant. The mean age at diagnosis was 40.61 years (IQR 31–47.25), 61% of patients being asymptomatic (n = 11, New York Heart Association (NYHA) class I) and 39% mildly symptomatic (n = 7, NYHA class II). Notably, 39% of patients (n = 7) presented with a clinical history of presumed myocarditis episodes, characterized by chest pain, myocardial enzyme release, 12-lead electrocardiogram abnormalities with normal coronary arteries, which were recurrent in 57% of cases (n = 4). About half of the patients (55%, n = 10) presented with a varied degree of left ventricular enlargement (LVE), four showing biventricular involvement. Eleven patients (61%) underwent implantable cardioverter defibrillator (ICD) implantation, with a mean age of 46.81 years (IQR 36.00–64.00). Cardiac magnetic resonance imaging (CMRI) identified in all 18 patients a delayed enhancement (DE) area consistent with left ventricular (LV) myocardial fibrosis, with a larger localization and extent in patients presenting with recurrent episodes of myocardial injury. These clinical and genetic data confirm that DSP-related cardiomyopathy may represent a distinct clinical entity characterized by a high arrhythmic burden, variable degrees of LVE, Late Gadolinium Enhancement (LGE) with subepicardial distribution and episodes of myocarditis-like picture. |
format | Online Article Text |
id | pubmed-9916412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99164122023-02-11 DSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort Di Lorenzo, Francesca Marchionni, Enrica Ferradini, Valentina Latini, Andrea Pezzoli, Laura Martino, Annamaria Romeo, Fabiana Iorio, Annamaria Bianchi, Stefano Iascone, Maria Calò, Leonardo Novelli, Giuseppe Mango, Ruggiero Sangiuolo, Federica Int J Mol Sci Article Variants in desmoplakin gene (DSP MIM *125647) have been usually associated with Arrhythmogenic Cardiomyopathy (ACM), or Dilated Cardiomyopathy (DCM) inherited in an autosomal dominant manner. A cohort of 18 probands, characterized as heterozygotes for DSP variants by a target Next Generation Sequencing (NGS) cardiomyopathy panel, was analyzed. Cardiological, genetic data, and imaging features were retrospectively collected. A total of 16 DSP heterozygous pathogenic or likely pathogenic variants were identified, 75% (n = 12) truncating variants, n = 2 missense variants, n = 1 splicing variant, and n = 1 duplication variant. The mean age at diagnosis was 40.61 years (IQR 31–47.25), 61% of patients being asymptomatic (n = 11, New York Heart Association (NYHA) class I) and 39% mildly symptomatic (n = 7, NYHA class II). Notably, 39% of patients (n = 7) presented with a clinical history of presumed myocarditis episodes, characterized by chest pain, myocardial enzyme release, 12-lead electrocardiogram abnormalities with normal coronary arteries, which were recurrent in 57% of cases (n = 4). About half of the patients (55%, n = 10) presented with a varied degree of left ventricular enlargement (LVE), four showing biventricular involvement. Eleven patients (61%) underwent implantable cardioverter defibrillator (ICD) implantation, with a mean age of 46.81 years (IQR 36.00–64.00). Cardiac magnetic resonance imaging (CMRI) identified in all 18 patients a delayed enhancement (DE) area consistent with left ventricular (LV) myocardial fibrosis, with a larger localization and extent in patients presenting with recurrent episodes of myocardial injury. These clinical and genetic data confirm that DSP-related cardiomyopathy may represent a distinct clinical entity characterized by a high arrhythmic burden, variable degrees of LVE, Late Gadolinium Enhancement (LGE) with subepicardial distribution and episodes of myocarditis-like picture. MDPI 2023-01-27 /pmc/articles/PMC9916412/ /pubmed/36768812 http://dx.doi.org/10.3390/ijms24032490 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Di Lorenzo, Francesca Marchionni, Enrica Ferradini, Valentina Latini, Andrea Pezzoli, Laura Martino, Annamaria Romeo, Fabiana Iorio, Annamaria Bianchi, Stefano Iascone, Maria Calò, Leonardo Novelli, Giuseppe Mango, Ruggiero Sangiuolo, Federica DSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort |
title | DSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort |
title_full | DSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort |
title_fullStr | DSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort |
title_full_unstemmed | DSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort |
title_short | DSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort |
title_sort | dsp-related cardiomyopathy as a distinct clinical entity? emerging evidence from an italian cohort |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916412/ https://www.ncbi.nlm.nih.gov/pubmed/36768812 http://dx.doi.org/10.3390/ijms24032490 |
work_keys_str_mv | AT dilorenzofrancesca dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort AT marchionnienrica dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort AT ferradinivalentina dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort AT latiniandrea dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort AT pezzolilaura dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort AT martinoannamaria dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort AT romeofabiana dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort AT iorioannamaria dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort AT bianchistefano dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort AT iasconemaria dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort AT caloleonardo dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort AT novelligiuseppe dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort AT mangoruggiero dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort AT sangiuolofederica dsprelatedcardiomyopathyasadistinctclinicalentityemergingevidencefromanitaliancohort |